2024-03-04
Drug treatment or bariatric surgery for type 2 diabetes ?
Endocrinology and Metabolism
In this pooled analysis of four U.S. clinical trials conducted between 2007 and 2013, researchers evaluated the long-term glycemic control and safety of bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding) compared with lifestyle measures coupled with drug therapy for type 2 diabetes. A total of 262 patients were followed for 7 to 12 years. At the end of this follow-up, patients who had undergone bariatric surgery had better glycemic control, less use of antidiabetic drugs and a higher rate of diabetes control, compared with patients who had benefited from hygienic-dietary measures coupled with medication.
Last press reviews
Gene therapy: a turning point for parkinson’s disease?
By Ana Espino | Published on April 7, 2026 | 4 min read<br><br><br>
Breast cancer: circulating tumor DNA, a key biomarker to anticipate relapse
By Elodie Vaz | Published on April 3, 2026 | 3 min read<br><br><br>B...
Gut microbiota: metabolites at the heart of cardiovascular risk
By Elodie Vaz | Published on April 3, 2026 | 4 min read<br><br><br>C...